MSH|^~\&|MYIIS|MyStateIIS|MYEHR|Myclinic|20201015001020-0500||RSP^K11^RSP_K11|7731029|P|2.5.1|||NE|NE|||||Z42^CDCPHINVS|A_Clinic^SOME_SYSTEM^^^^X68^AN^^^A_Clinic1234|
MSA|AA|793543||||
QAK|37374859|OK|Z44^Request Evaluated History and Forecast^CDCPHINVS|||
QPD|Z44^Request Evaluated History and Forecast^CDCPHINVS|37374859||Vazquez^Juana^Mariana^^^^L|Acosta^Maria^Merida^^^^M|201511011105|F|4345 Standish Way^^Stamford^CT^^^L|^PRN^CP^^1^203^5551212
PID|1||123456^^^MYEHR^MR~987633^^^MYIIS^SR||Vazquez^Juana^Mariana^^^^L|Acosta^Maria^Merida^^^^M|201511011105|F||2106-3^White^CDCREC|4345 Standish Way^^Stamford^CT^06903^USA^L||^^^^1^203^5551212||eng^English^ISO639|||||||2135-2^Hispanic or Latino^CDCREC
ORC|RE||197027^SH|||||||^Sirtis^Lisa||^Carter^Jane^^^^^^^L^^^^^^^^^^^MD|||||SH^Shoreline Hospital^HL70362
RXA|0|1|20151101|20151101|08^hepatitis B vaccine, pediatric or pediatric/adolescent dosage^CVX^58160-0820-43^ENGERIX-B^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Carter^Jane^^^^^^^L^^^^^^^^^^^MD|^^^SH||||6332FK33|20151214|SKB^GlaxoSmithKline Biologicals SA^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|45^hepatitis B vaccine, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20151031
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|3|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197028^SP|||||||^Molina^Sandra||^Smith^Frank^^^^^^^L^^^^^^^^^^^MD|||||SP^Shoreline Pediatrics^HL70362||||||||||||||
RXA|0|1|20151220|20151220|45^hepatitis B vaccine, unspecified formulation^CVX^58160-0820-43^ENGERIX-B^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Molina^Sandra|^^^SP^^^^^400 Shoreline Drive^^Stamford^CT^06901||||6352FK1|20151231|SKB^GlaxoSmithKline Biologicals SA^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|RT^Right Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|45^hepatitis B vaccine, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20151031
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|3|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||1970278^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160520|20160520|08^hepatitis B vaccine, pediatric or pediatric/adolescent dosage^CVX^58160-0820-43^ENGERIX-B^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP||||6352FK24|20170831|SKB^GlaxoSmithKline Biologicals SA^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|45^hepatitis B vaccine, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160520
OBX|3|NM|30973-2^dose number in series^LN|1|3|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|3|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160122|20160122|106^diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified^CVX^49281-0286-58^DAPTACEL^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP||||D409QS2341|20161130|PMC^Sanofi Pasteur Inc^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|107^diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160123
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|5|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
OBX|6|TS|29768-9^VIS Publication Date^LN|1|20150224||||||F|||20160123
OBX|7|DT|29769-7^VIS presented^LN|1|20160122||||||F
OBX|8|CE|69764-9^Document type^LN|1|253088698300027111150224^Diphtheria/Tetanus/Pertussis (DTaP) VIS^cdcgs1vis||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160323|20160323|106^diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis^CVX^49281-0286-58^DAPTACEL^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP||||D409QS2433|20160904|PMC^Sanofi Pasteur Inc^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|RT^Right Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|107^diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160323
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|5|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
OBX|6|TS|29768-9^VIS Publication Date^LN|1|20150224||||||F|||20160323
OBX|7|DT|29769-7^VIS presented^LN|1|20160323||||||F
OBX|8|CE|69764-9^Document type^LN|1|253088698300027111150224^Diphtheria/Tetanus/Pertussis (DTaP) VIS^cdcgs1vis||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160522|20160522|106^diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis^CVX^49281-0286-58^DAPTACEL^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP||||D409QS3255|20161201|PMC^Sanofi Pasteur Inc^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|107^diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160522
OBX|3|NM|30973-2^dose number in series^LN|1|3|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|5|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
OBX|6|TS|29768-9^VIS Publication Date^LN|1|20150224||||||F|||20160522
OBX|7|DT|29769-7^VIS presented^LN|1|20160522||||||F
OBX|8|CE|69764-9^Document type^LN|1|253088698300027111150224^Diphtheria/Tetanus/Pertussis (DTaP) VIS^cdcgs1vis||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20170221|20170221|106^diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis^CVX^49281-0286-58^DAPTACEL^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP||||D409QS249|20170301|PMC^Sanofi Pasteur Inc^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|107^diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20170221
OBX|3|NM|30973-2^dose number in series^LN|1|4|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|5|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
OBX|6|TS|29768-9^VIS Publication Date^LN|1|20150224||||||F|||20170221
OBX|7|DT|29769-7^VIS presented^LN|1|20170221||||||F
OBX|8|CE|69764-9^Document type^LN|1|253088698300027111150224^Diphtheria/Tetanus/Pertussis (DTaP) VIS^cdcgs1vis||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160122|20160122|49^Haemophilus influenzae type b vaccine, PRP-OMP conjugate^CVX^00006-4897-01^PedvaxHIB^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP||||7M54K9245|20160324|MSD^Merck Sharp and Dohme Corp^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|RT^Right Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|17^Hib, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160122
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160323|20160323|49^Haemophilus influenzae type b vaccine, PRP-OMP conjugate^CVX^00006-4897-01^PedvaxHIB^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||7M55K3342|20161030|MSD^Merck Sharp and Dohme Corp^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|17^Hib, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160323
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160522|20160522|49^Haemophilus influenzae type b vaccine, PRP-OMP conjugate^CVX^00006-4897-01^PedvaxHIB^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||7M75K4566|20160523|MSD^Merck Sharp and Dohme Corp^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|RT^Right Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|17^Hib, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160522
OBX|3|NM|30973-2^dose number in series^LN|1|3|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20161121|20161121|49^Haemophilus influenzae type b vaccine, PRP-OMP conjugate^CVX^00006-4897-01^PedvaxHIB^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||7M53K5534|20170222|MSD^Merck Sharp and Dohme Corp^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|17^Hib, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20161121
OBX|3|NM|30973-2^dose number in series^LN|1|4|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160122|20160122|10^poliovirus vaccine, inactivated^CVX^49281-0860-88^IPOL^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||D333PV2431|20161004|PMC^Sanofi Pasteur Inc^MVX|||CP|A|||||
RXR|C38299^Subcutaneous^NCIT^SC^Subcutaneous^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|10^poliovirus vaccine, inactivated^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160122
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160323|20160323|10^poliovirus vaccine, inactivated^CVX^49281-0860-88^IPOL^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||D333PV4344|20170323|PMC^Sanofi Pasteur Inc^MVX|||CP|A|||||
RXR|C38299^Subcutaneous^NCIT^SC^Subcutaneous^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|31044-1^Reaction^LN|1|VXC11^convulsions (fits, seizures) within 72 hours of dose^CDCPHINVS||||||F|||20160323|||||||||||
OBX|2|CE|30956-7^vaccine type^LN|1|10^poliovirus vaccine, inactivated^CVX||||||F
OBX|3|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160323
OBX|4|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|5|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|6|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160122|20160122|133^pneumococcal conjugate vaccine, 13 valent^CVX^00005-1971-01^PREVNAR 13^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||P243V3281|20160130|PFR^Pfizer, Inc^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^IM^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|109^pneumococcal, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160122
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160323|20160323|133^pneumococcal conjugate vaccine, 13 valent^CVX^00005-1971-01^PREVNAR 13^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||P343V8321|20160330|PFR^Pfizer, Inc^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|109^pneumococcal, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160323
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160522|20160522|133^pneumococcal conjugate vaccine, 13 valent^CVX^00005-1971-01^PREVNAR 13^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||P853V2164|20160830|PFR^Pfizer, Inc^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|RT^Right Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|109^pneumococcal, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160522
OBX|3|NM|30973-2^dose number in series^LN|1|3|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20170111|20170111|133^pneumococcal conjugate vaccine, 13 valent^CVX^00005-1971-01^PREVNAR 13^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||P853V58532|20170418|PFR^Pfizer, Inc^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|109^pneumococcal, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20170111
OBX|3|NM|30973-2^dose number in series^LN|1|4|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160122|20160122|119^rotavirus, live, monovalent vaccine^CVX^58160-0851-01^ROTARIX^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||6359RV533|20160215|SKB^GlaxoSmithKline Biologicals SA^MVX|||CP|A|||||
RXR|C38288^Oral^NCIT^PO^Oral^HL70162|||||
OBX|1|CE|30956-7^vaccine type^LN|1|122^rotavirus, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160122
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|3|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160323|20160323|119^rotavirus, live, monovalent vaccine^CVX^58160-0851-01^ROTARIX^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||6359RV932|20160510|SKB^GlaxoSmithKline Biologicals SA^MVX|||CP|A|||||
RXR|C38288^Oral^NCIT^PO^Oral^HL70162|||||
OBX|1|CE|30956-7^vaccine type^LN|1|122^rotavirus, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160323
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|3|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20160925|20160925|161^Influenza, injectable,quadrivalent, preservative free, pediatric^CVX^49281-0516-00^FLUZONE^NDC|0.25|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||D8043IN8734|20170725|PMC^Sanofi Pasteur^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|88^influenza, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160925
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|2|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20161029|20161029|161^Influenza, injectable,quadrivalent, preservative free, pediatric^CVX^49281-0516-00^FLUZONE^NDC|0.25|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||D8043IN8746|20170312|PMC^Sanofi Pasteur^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|RT^Right Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|88^influenza, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20161029
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|2|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20171002|20171002|161^Influenza, injectable, quadrivalent, preservative free, pediatric^CVX^49281-0517-00^FLUZONE QUADRIVALENT^NDC|.25|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||D9334IN9333|20180522|PMC^Sanofi Pasteur^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|88^influenza, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20171002
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20181104|20181104|161^Influenza, injectable,quadrivalent, preservative free, pediatric^CVX^49281-0518-00^FLUZONE QUADRIVALENT^NDC|0.25|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||D9553IN2243|20190430|PMC^Sanofi Pasteur^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|88^influenza, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20181104
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20161123|20161123|83^hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule^CVX^58160-0825-43^HAVRIX^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||6359RT33|20170104|SKB^GlaxoSmithKline Biologicals SA^MVX|||CP|A|||||
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|RD^Right Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|85^Hep A, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20161123
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|2|NA^^HL70353|||||F
OBX|5|TS|29768-9^VIS Publication Date^LN|1|20160720||||||F|||20161123
OBX|6|DT|29769-7^VIS presented^LN|1|20161123||||||F
OBX|7|CE|69764-9^Document type^LN|1|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20170523|20170523|83^hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule^CVX^58160-0825-43^HAVRIX^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||6359RT48|20170911|SKB^GlaxoSmithKline Biologicals SA^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|85^Hep A, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20170524
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|2|NA^^HL70353|||||F
OBX|5|TS|29768-9^VIS Publication Date^LN|1|20160720||||||F|||20170524
OBX|6|DT|29769-7^VIS presented^LN|1|20170523||||||F
OBX|7|CE|69764-9^Document type^LN|1|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F
ORC|RE||197028^SP|||||||^Molina^Sandra||^Smith^Frank^^^^^^^L^^^^^^^^^^^MD|||||SP^Shoreline Pediatrics^HL70362||||||||||||||
RXA|0|1|20160822|20160822|03^measles, mumps, rubella virus vaccine^CVX^00006-4681-01^MMR II^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Molina^Sandra|^^^SP^^^^^400 Shoreline Drive^^Stamford^CT^06901||||0853CC|20161215|MSD^Merck Sharp and Dohme Corp^MVX|||CP|A|||||
RXR|C38299^Subcutaneous^NCIT^SC^Subcutaneous^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|03^MMR^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160822
OBX|3|ID|59781-5^Dose validity^LN|1|N||||||F
OBX|4|CE|30982-3^Reason code^LN|1|264499004^Early^SCT||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190922|20190922|03^measles, mumps, rubella virus vaccine^CVX^00006-4681-01^MMR II^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||0854FF|20200413|MSD^Merck Sharp and Dohme Corp^MVX|||CP|A|||||
RXR|C38299^Subcutaneous^NCIT^SC^Subcutaneous^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|03^MMR^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20191122
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|2|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J||^Herrera^Carlos^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20171215|20171215|21^varicella virus vaccine^CVX^00006-4827-01^Varivax^NDC|0.5|mL^^UCUM||00^new immunization record^NIP001|^Martinez^J|^^^OP^^^^^333 Oceanview Lane^^Stamford^CT^06901||||2341BB|20181201|MSD^Merck Sharp and Dohme Corp^MVX|||CP|A|||||
RXR|C38299^Subcutaneous^NCIT^SC^Subcutaneous^HL70162|RD^Right Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|21^Varicella virus vaccine^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20171215
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|2|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||9999^OP|||||||^Clerk^Myron|||||||STIIS^StateIIS^HL70362
RXA|0|1|20160429|20160429|998^no vaccine admin^CVX|999||||||||||||||NA
OBX|1|CE|30956-7^vaccine type^LN|1|10^IPV^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20160429
OBX|3|DT|30980-7^Date vaccination due^LN|1|20160429||||||F
OBX|4|DT|30981-5^Earliest date to give^LN|1|20160429||||||F
OBX|5|DT|59778-1^Date dose is overdue^LN|1|20170430||||||F
OBX|6|NM|30973-2^dose number in series^LN|1|3|NA^^HL70353|||||F|||20160429
ORC|RE||9999^OP|||||||^Clerk^Myron|||||||STIIS^StateIIS^HL70362
RXA|0|1|20201021|20201021|998^no vaccine admin^CVX|999||| |||||||||||NA
OBX|1|CE|30956-7^vaccine type^LN|1|88^influenza, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20201021
OBX|3|DT|30981-5^Earliest date to give^LN|1|20200901||||||F
OBX|4|DT|30980-7^Date vaccination due^LN|1|20200901||||||F
ORC|RE||9999^OP|||||||^Clerk^Myron|||||||STIIS^StateIIS^HL70362
RXA|0|1|20201031|20201031|998^no vaccine admin^CVX|999||| |||||||||||NA
OBX|1|CE|30956-7^vaccine type^LN|1|03^MMR^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20201031
OBX|3|DT|30981-5^Earliest date to give^LN|1|20191031||||||F
OBX|4|DT|30980-7^Date vaccination due^LN|1|20191031||||||F
OBX|5|DT|59778-1^Date dose is overdue^LN|1|20211031||||||F
OBX|6|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F|||20201031
OBX|7|NM|59782-3^number of doses in series^LN|1|2|NA^^HL70353|||||F
ORC|RE||9999^OP|||||||^Clerk^Myron|||||||STIIS^StateIIS^HL70362
RXA|0|1|20201031|20201031|998^no vaccine admin^CVX|999||| |||||||||||NA
OBX|1|CE|30956-7^vaccine type^LN|1|21^Varicella^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20201031
OBX|3|DT|30981-5^Earliest date to give^LN|1|20191031||||||F
OBX|4|DT|30980-7^Date vaccination due^LN|1|20191031||||||F
OBX|5|DT|59778-1^Date dose is overdue^LN|1|20211031||||||F
OBX|6|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F|||20201031
OBX|7|NM|59782-3^number of doses in series^LN|1|2|NA^^HL70353|||||F